Table 2.
Results of statistical analysis of associations between systemic concentrations of examined immunoresolvents and clinical staging of pancreatic cancer in patients (modelling using multivariate regression analysis).
| Dependent variable | Independent variable | β | P of the variable | R2 | P of the model |
|---|---|---|---|---|---|
| TNM Staging* | Lipoxin A4 | 0.08 | 0.51 | 0.01 | 0.51 |
| Lipoxin B4 | 0.13 | 0.28 | 0.02 | 0.28 | |
| Resolvin D1 | 0.03 | 0.81 | 0.001 | 0.81 | |
| Resolvin D2 | 0.001 | 0.99 | 0.001 | 0.99 |
β – standardized coefficient in the regression equation; p – level of significance.
*Variable was created by assigning 1, 2, 3 or 4 value to appropriate TNM stage that was present in patients with pancreatic cancer.